Active, Not Recruiting
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
NCT03814746
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
- Locations
-
- Childrens Healthcare of Atlanta Atlanta, Georgia, United States
- Boston Medical Center Boston, Massachusetts, United States
- Levine Cancer Insitute Carolinas Healthcare System Charlotte, North Carolina, United States
- Univ of Tenn Health Sciences Ctr Memphis, Tennessee, United States